

Blood glucose monitoring devices play a crucial role in managing type 1 diabetes (T1D). These devices, especially continuous glucose monitoring (CGM) systems, have transformed diabetes care by improving glycemic control, reducing health complications, and enhancing the quality of life for individuals with T1D. This review explores their journey from U.S. Food and Drug Administration (FDA) approval to widespread market availability, focusing on advancements in technology and the impact on T1D management.
Advancements in CGM Devices
Continuous glucose monitoring devices have revolutionized T1D management by offering real-time data and actionable insights. Innovations such as electrochemical sensors have paved the way for more accurate and user-friendly devices. FDA-approved systems like the Dexcom G6, G7, and FreeStyle Libre 3 deliver significant improvements in monitoring and glycemic outcomes.
Here are the key points for each blood glucose monitoring device mentioned in the document:
Modified Clark Enzyme Electrode
Provides a larger surface area for the working electrode.
Not FDA approved yet.
Senseonics Eversense (FDA approved in 2018)
Implantable sensor that measures glucose for 90 days.
Sends information to a mobile app for alerts on glucose fluctuations.
Mean absolute relative difference (MARD) of 11.1%.
Some limitations include a complicated removal process and a 24-hour delay in glucose readings post-implantation.
MiniMedâ„¢ 780G and Guardianâ„¢ 4 Sensor (FDA approved in 2018)
Minimally invasive with demonstrated safety.
Provides improvements in glycemic control and reduces the burden of T1D management.
Dexcom G6 (FDA cleared in 2018)
Minimally invasive with improved glycemic control.
Capable of capturing hypoglycemic events.
Offers smartphone app connectivity and additional alerts.
Dexcom G7 (FDA cleared in 2022)
Reduced warm-up time to 27 minutes and extended wear duration.
Enhanced accuracy and smaller design.
Offers advanced alert systems and calibration-free operation.
FreeStyle Libre 3 (FDA cleared in 2022)
Higher accuracy with real-time glucose monitoring and minute-by-minute updates.
Water-resistant and no fingerstick calibration required.
Raman Spectroscopy
A non-invasive technique that measures blood glucose using light.
Limited by challenges in achieving clinical significance and accuracy; no FDA approval yet.
Zinc Oxide Micropipette Tip
Uses affordable plastic to reduce costs and shows faster electron transfer.
Not yet translated into a specific CGM device and lacks FDA approval.
Economic and Healthcare Impact
Diabetes imposes a significant economic burden in the U.S. CGMs help reduce long-term complications, ultimately lowering healthcare costs. Their potential expansion into managing type 2 diabetes (T2D) and gestational diabetes mellitus (GDM) represents a future direction for enhancing diabetes care and technology.
Conclusion
The evolution of CGMs has improved T1D management by enhancing accuracy, usability, and patient outcomes. As technology advances, the integration of these devices into broader diabetes management strategies promises further innovations, improving lives and reducing healthcare burdens.
Citations
Mittal, R., Koutras, N., Maya, J., Lemos, J. R. N., & Hirani, K. (2024). Blood glucose monitoring devices for type 1 diabetes: A journey from the Food and Drug Administration approval to market availability. Frontiers in Endocrinology, 15, 1352302. https://doi.org/10.3389/fendo.2024.1352302
Statement:
Any third-party content and/or sources provided on this page (such as articles or journals) are authored and published by persons and entities unaffiliated with Backed-By-Science. Such content and sources are provided for informational and educational purposes only and are not endorsed or otherwise encouraged by Backed-By-Science.
Always seek a healthcare professional for advice that caters to your specific needs.
The content on this page is provided solely for informational and educational purposes and does not constitute medical or other professional advice. The content on this page does not constitute a call to any form of action, recommendation, or endorsement of any medical, therapeutic, or other professional service or advice. Always seek a healthcare professional for advice that caters to your specific needs.